undamentalytics Newsletter

Milne George M Jr: insider trades

Director at 4 companies we cover. 5 open-market purchases and 13 sales not made under a pre-set plan, reported from March 7, 2011 to September 5, 2024.

Would copying Milne George M Jr’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 4 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on August 12, 2011 into $5,456 by November 2, 2026, −3.9% a year. The copy held shares only 26% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $20,016, +4.7% a year (the S&P 500 held throughout made $83,592, +15.0% a year). Beta against the index was 0.42. Twelve months after each report, the average purchase was −30.3% against the S&P 500 (median −19.4%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −29.0%. After their sales, the shares moved +10.0% against the index over 12 months on average (a negative figure means selling was the right call); 23% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$25.0k$50.0k$75.0k 20112013201520172019202120232025 $83.6k$20.0k$5.5k
Copying Milne George M JrS&P 500, same days investedS&P 500, held throughout $10,000 copying Milne George M Jr’s open-market purchases from August 12, 2011, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−3.9%
S&P 500, same days invested
+4.7% (held throughout +15.0%)
Time in shares
26%
Sharpe ratio (S&P 500)
0.03 (0.81)
Biggest drop (S&P 500)
−88% (−34%)
Market sensitivity (beta)
0.42
Purchases copied
4

Trade by trade

Milne George M Jr: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 4 +3.0% +3.9% 75% 4 0.50 0.65 No reliable evidence
Purchases, 6 months after the report 4 +0.5% +2.2% 50% 4 0.03 0.98 No reliable evidence
Purchases, 12 months after the report 4 −30.3% −19.4% 0% 4 −2.19 0.12 No reliable evidence
Purchases, 12 months after the trade 4 −29.0% −20.8% 0% 4 −2.10 0.13 No reliable evidence
Sales, 3 months after the report 13 +3.4% +7.6% 31% 8 0.71 0.50 No reliable evidence
Sales, 12 months after the report 13 +10.0% +7.6% 23% 8 1.44 0.19 No reliable evidence
Sales, 12 months after the trade 13 +9.8% +9.2% 31% 8 1.37 0.21 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Mettler Toledo MTD —17March 7, 2011February 24, 2016
Charles River Laboratories CRL —06February 18, 2014March 2, 2021
Aurinia Pharmaceuticals Inc. AUPH —30March 9, 2021March 6, 2023
Amylyx Pharmaceuticals, Inc. AMLX —10September 5, 2024September 5, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
September 5, 2024September 3, 2024 AMLX Purchase $220,000 not yetnot yetnot yet
March 6, 2023March 2, 2023 AUPH Purchase $178,200 +7.6%−70.9%−66.3%
March 8, 2022March 4, 2022 AUPH Purchase $54,100 +15.9%−14.6%−8.2%
March 9, 2021March 5, 2021 AUPH Purchase $65,000 −11.9%−24.3%−33.3%
March 2, 2021March 1, 2021 CRL Sale $1,023,735 +7.9%−13.2%−13.0%
February 19, 2020February 18, 2020 CRL Sale $1,262,422 +11.6%+47.1%+51.5%
February 25, 2019February 22, 2019 CRL Sale $649,220 −10.0%+0.8%−1.9%
February 24, 2016February 23, 2016 CRL Sale $762,322 +9.2%−3.2%−4.3%
February 24, 2016February 22, 2016 MTD Sale $840,762 +8.3%+25.8%+22.1%
February 23, 2015February 20, 2015 MTD Sale $2,820,083 +4.0%+7.6%+9.2%
February 23, 2015February 20, 2015 CRL Sale $455,227 −5.4%+2.4%+1.7%
August 12, 2014August 11, 2014 MTD Sale $782,670 +3.4%+12.6%+16.3%
February 18, 2014February 13, 2014 CRL Sale $351,289 −11.4%+11.9%+9.2%
November 23, 2012November 20, 2012 MTD Sale $539,130 +7.6%+5.1%+5.7%
August 29, 2012August 28, 2012 MTD Sale $214,500 +11.7%+17.0%+14.8%
August 23, 2012August 21, 2012 MTD Sale $282,081 +14.2%+19.8%+18.6%
August 11, 2011August 10, 2011 MTD Purchase $143,140 +0.2%−11.5%−8.0%
March 7, 2011March 3, 2011 MTD Sale $526,680 −7.2%−4.2%−2.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Milne George M Jr traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.